TYK2 and psoriasis: Unlike JAK1, JAK2, and JAK3, TYK2 uniquely mediates intracellular signaling for key pro-inflammatory cytokines such as interleukin (IL)-12, IL-23, and type I interferons [2], which are central to the pathogenesis of psoriasis and other immune-mediated disorders.